New Treatments for Castration-Resistant Prostate Cancer: >Highlights from the 44th Annual Meeting of the American Society of Clinical Oncology, May 30–June 3, 2008, Chicago, IL

摘要

Most of us were taught in medical school that prostate cancer was exquisitely dependent on circulating androgens and that castration, whether surgical or medical, resulted in significant decrease in tumor mass, associated pain in the setting of metastatic disease, and reduction in acid phosphates and prostate-specific antigen (PSA).